SCHEMBL24087900

SCHEMBL24087900

O=C(O)CSc1nc(C(F)(F)F)c(F)c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 1/20 0.47
▸ KDM4E B2RXH2 4/20 0.45
▸ LMNA P02545 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ ALDH1A1 P00352 4/20 0.43
▸ ATM Q13315 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CSNK2A2 P19784 2/20 0.41
▸ CSNK2A1 P68400 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CSNK2B P67870 1/20 0.41
▸ PRKAG1 P54619 1/20 0.40
▸ PRKAA2 P54646 1/20 0.40
▸ PRKAB1 Q9Y478 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847427 0.87 DAO (0.43) DAOKDM4ELMNAMAPTALDH1A1
SCHEMBL24087901 0.71 DAO (0.43) DAOKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL23853477 0.71 FABP4 (0.65) KDM4EMAPTALDH1A1KMT2APRKAG1
SCHEMBL26847431 0.70 DAO (0.44) DAOKDM4ELMNAMAPTALDH1A1
SCHEMBL16775313 0.66 CA12 (0.66) MAPTALDH1A1SMN1; SMN2KMT2ATDP1
SCHEMBL13381566 0.66 HPGD (0.77) KDM4ELMNAMAPTALDH1A1HTT
SCHEMBL16775312 0.65 CA12 (0.65) MAPTALDH1A1SMN1; SMN2KMT2ATDP1
SCHEMBL14485852 0.64 DAO (1.00) DAOMAPTALDH1A1HTTSMN1; SMN2
SCHEMBL11119849 0.64 KMT2A (0.60) MAPTALDH1A1KMT2APRKAG1PRKAA2
SCHEMBL20340015 0.64 KDM4E (0.58) KDM4ELMNAMAPTALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 DAO 66/4885KDM4E 1110/4885LMNA 2315/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 DAO 66/4885KDM4E 1110/4885LMNA 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback